Filing Flows › Black Diamond Therapeutics (BDTX) › Who owns the stock
Who owns Black Diamond Therapeutics (BDTX) stock
96 funds reported Black Diamond Therapeutics (BDTX) shares in their latest 13F filings, worth $67.9M in all. The largest holder is NEA Management Company, LLC ($8.2M). Last quarter 52 funds added to their stakes and 51 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| NEA Management Company, LLC | 4,448,757 | $8.2M | unchanged | 2026-06-30 |
| T. Rowe Price Investment Management | 4,028,202 | $7.5M | decrease | 2026-06-30 |
| BlackRock | 3,917,088 | $7.2M | increase | 2026-06-30 |
| Vanguard Group | 2,188,857 | $5.3M | unchanged | 2025-12-31 |
| Acadian Asset Management LLC | 2,348,651 | $4.3M | unchanged | 2026-06-30 |
| Vanguard Capital Management LLC | 2,125,270 | $3.9M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 1,962,394 | $3.6M | increase | 2026-06-30 |
| Defilade Capital Management, L.P. | 1,674,999 | $3.1M | new | 2026-06-30 |
| Dimensional Fund Advisors LP | 1,365,384 | $2.5M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 1,218,171 | $2.3M | increase | 2026-06-30 |
| Connor, Clark & Lunn Investment Management | 1,092,885 | $2.0M | increase | 2026-06-30 |
| Marshall Wace, LLP | 896,602 | $1.7M | increase | 2026-06-30 |
| Bridgeway Capital Management, LLC | 791,434 | $1.5M | increase | 2026-06-30 |
| FMR LLC | 643,668 | $1.2M | increase | 2026-06-30 |
| Balyasny Asset Management L.P. | 542,172 | $1.0M | increase | 2026-06-30 |
Black Diamond Therapeutics' latest quarter
Black Diamond Therapeutics, Q1 2025: revenue $70.0M, operating margin 77.9%, net earnings $56.5M, operating cash flow $53.4M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BDTX stock?
By the latest 13F filings: NEA Management Company, LLC ($8.2M); T. Rowe Price Investment Management ($7.5M); BlackRock ($7.2M); Vanguard Group ($5.3M); Acadian Asset Management LLC ($4.3M).
What is the short interest in BDTX?
5,002,599 shares were sold short at the 2026-10-15 settlement, 4.75% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.